Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06581393 · ClinicalTrials.gov registry record · NA
First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings
A NA study of End Stage Renal Disease and End-Stage Kidney Disease, sponsored by Diality.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06581393 is a NA study of End Stage Renal Disease and End-Stage Kidney Disease that has completed, run by Diality. The registered enrollment target is 12 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06581393, a NA study of End Stage Renal Disease and End-Stage Kidney Disease, has completed, sponsored by Diality.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a non-significant risk study utilizing a device cleared for use by the FDA under its 510(k) clearance. Consented patients will complete their usual dialysis treatment under professional care in an ICHD (In-Center Hemodialysis) setting.
Conditions Studied
Interventions
- DEVICE Moda-flx Hemodialysis System
Study Locations (1)
California
- North America Research Institute - Ontario
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-12-09 |
| Est. Completion | 2025-04-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06581393
The ClinicalTrials.gov registry entry for NCT06581393 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (99% lower). The listed sponsor is Diality, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with End Stage Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which Moda-flx Hemodialysis System is the first listed.
NCT06581393 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06581393 about?
NCT06581393 is a clinical study titled "First Evaluation of the Moda-Flx Hemodialysis System™ in Real World Clinical Settings". This is a non-significant risk study utilizing a device cleared for use by the FDA under its 510(k) clearance. Consented patients will complete their usual dialysis treatment under professional care in an ICHD (In-Center Hemodialysis) setting.
What is the current status of trial NCT06581393?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2024-12-09. Estimated completion is 2025-04-28.
What conditions does trial NCT06581393 study?
This clinical trial studies the following conditions: End Stage Renal Disease, End-Stage Kidney Disease, End Stage Renal Disease on Dialysis.
What interventions are being tested in trial NCT06581393?
The interventions under investigation include: Moda-flx Hemodialysis System (DEVICE).
Who is sponsoring clinical trial NCT06581393?
This trial is sponsored by Diality, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06581393 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Renal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
RECRUITING · NA
-
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
RECRUITING · NA
-
CAPABLE Transplant
RECRUITING · NA
-
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.